Evaluation of the role of HMGA1 protein in colon cancer stem cells

Detalhes bibliográficos
Autor(a) principal: Monteiro, Inês Filipa Soares
Data de Publicação: 2023
Tipo de documento: Dissertação
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10773/40519
Resumo: Colorectal cancer, with over 1.9 million cases in 2020 and ranking second in cancer-related deaths, is increasing in highly developed countries. Cancer stem cells (CSCs), related to tumour initiation and chemotherapy resistance, are a significant focus in cancer research. Transcription factors (TFs) like SOX2, CMYC, and OCT4 are used to identify these cells. The lentiviral SORE6 reporter system, developed by Tang et al. (2015), allows the detection and characterization of CSCs by using a green fluorescent protein (GFP) under the control of a promoter with binding sites for SOX2 and OCT4. HMGA1 protein, overexpressed in several types of cancer, influences gene expression through chromatin changes, and is linked to stemness TFs, such as SOX2, OCT4, KLF4, and NANOG. In colorectal cancer, HMGA1 is crucial for maintaining a stem cell phenotype. The aim of this study was to investigate and establish the functional relevance of this protein in colon CSCs. We started by evaluating if HMGA1 levels, assessed by immunohistochemistry in 219 stage II CRC patient samples, were statistically correlated with clinicopathological and molecular characteristics of the tumours. We found that tumours with high HMGA1 expression were significantly associated with MMR-proficiency and SOX2 expression. Nevertheless, no prognostic or predictive value for HMGA1 expression was found. Aiming to use the SORE6 reporter to detect CSCs, a transduction of two CRC cell lines, HCT116 and SW480, with the SORE6 reporter vector was performed, and later two cell subpopulations, SORE6⁺ (GFP⁺) and SORE6ˉ (GFPˉ) were established through Fluorescence Activated Cell Sorting (FACS). Even though SOX2 expression was higher in SORE6⁺ cells (CSC-like), as expected, HCT116 cells showed less HMGA1 expression, when comparing to SORE6ˉ cells. Only SW480 had more expression of these two proteins in SORE6⁺ cells. Then, HMGA1 overexpression was performed by transducing both SORE6ˉ and SORE6⁺ sub-populations of HCT116 and SW480 cell lines with a DOX-inducible lentiviral vector, to understand if this protein has a role in the acquisition of stemness characteristics by colon cells and to evaluate phenotypic changes related to the establishment of colon CSCs. Unfortunately, the infection of SW480 revealed unsuccessful. The HCT116 HMGA1 transduced cells had a GFP gain was observed, through flow cytometry, but only in SORE6⁺ HMGA1 transduced cells. Regarding SOX2 and C-MYC expression in these cells, while SOX2 appeared to be inhibited by HMGA1, C-MYC seemed up-regulated by this protein. OCT4 had very low levels of expression in both cells and was not further evaluated. Through functional assays, no significant differences in stemness were observed after transducing SORE6 cells with HMGA1, either by using clonogenic or 5-FU resistance assays.
id RCAP_8ef0a7d6566b8e8e5138fcec038548e0
oai_identifier_str oai:ria.ua.pt:10773/40519
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Evaluation of the role of HMGA1 protein in colon cancer stem cellsColorectal cancerCancer stem cellsHMGA1SORE6Viral transductionStemnessColorectal cancer, with over 1.9 million cases in 2020 and ranking second in cancer-related deaths, is increasing in highly developed countries. Cancer stem cells (CSCs), related to tumour initiation and chemotherapy resistance, are a significant focus in cancer research. Transcription factors (TFs) like SOX2, CMYC, and OCT4 are used to identify these cells. The lentiviral SORE6 reporter system, developed by Tang et al. (2015), allows the detection and characterization of CSCs by using a green fluorescent protein (GFP) under the control of a promoter with binding sites for SOX2 and OCT4. HMGA1 protein, overexpressed in several types of cancer, influences gene expression through chromatin changes, and is linked to stemness TFs, such as SOX2, OCT4, KLF4, and NANOG. In colorectal cancer, HMGA1 is crucial for maintaining a stem cell phenotype. The aim of this study was to investigate and establish the functional relevance of this protein in colon CSCs. We started by evaluating if HMGA1 levels, assessed by immunohistochemistry in 219 stage II CRC patient samples, were statistically correlated with clinicopathological and molecular characteristics of the tumours. We found that tumours with high HMGA1 expression were significantly associated with MMR-proficiency and SOX2 expression. Nevertheless, no prognostic or predictive value for HMGA1 expression was found. Aiming to use the SORE6 reporter to detect CSCs, a transduction of two CRC cell lines, HCT116 and SW480, with the SORE6 reporter vector was performed, and later two cell subpopulations, SORE6⁺ (GFP⁺) and SORE6ˉ (GFPˉ) were established through Fluorescence Activated Cell Sorting (FACS). Even though SOX2 expression was higher in SORE6⁺ cells (CSC-like), as expected, HCT116 cells showed less HMGA1 expression, when comparing to SORE6ˉ cells. Only SW480 had more expression of these two proteins in SORE6⁺ cells. Then, HMGA1 overexpression was performed by transducing both SORE6ˉ and SORE6⁺ sub-populations of HCT116 and SW480 cell lines with a DOX-inducible lentiviral vector, to understand if this protein has a role in the acquisition of stemness characteristics by colon cells and to evaluate phenotypic changes related to the establishment of colon CSCs. Unfortunately, the infection of SW480 revealed unsuccessful. The HCT116 HMGA1 transduced cells had a GFP gain was observed, through flow cytometry, but only in SORE6⁺ HMGA1 transduced cells. Regarding SOX2 and C-MYC expression in these cells, while SOX2 appeared to be inhibited by HMGA1, C-MYC seemed up-regulated by this protein. OCT4 had very low levels of expression in both cells and was not further evaluated. Through functional assays, no significant differences in stemness were observed after transducing SORE6 cells with HMGA1, either by using clonogenic or 5-FU resistance assays.O cancro colorretal, com mais de 1,9 milhões de casos em 2020 e classificado como a segunda causa de morte relacionada com cancro, está a aumentar em países altamente desenvolvidos. As células estaminais de cancro, relacionadas com a iniciação tumoral e resistência à quimioterapia, são um foco significativo na investigação do cancro. Fatores de transcrição como SOX2, C-MYC e OCT4 são usados para a identificação destas células. O sistema-repórter lentivírico SORE6, desenvolvido por Tang et al. (2015), permite detetar e caracterizar as células estaminais do cancro (CSCs) através de uma proteína fluorescente (GFP) que está sob o controlo de um promotor que contém locais de ligação para SOX2 e OCT4. A proteína HMGA1, que está sobre-expressa em vários tipos de cancro, influencia a expressão de genes através de alterações na cromatina e está associada a fatores de transcrição relacionados com a estaminalidade, como o SOX2, OCT4, KLF4 e NANOG. No cancro colorretal, a HMGA1 é essencial para manter o fenótipo de células estaminais. O objetivo deste estudo foi investigar a relevância funcional desta proteína nas CSCs do cólon. Inicialmente, avaliámos os níveis de HMGA1 em 219 amostras de pacientes com cancro colorretal em estadio II por imunohistoquímica e encontrámos uma associação estatisticamente significativa entre os casos com expressão elevada de HMGA1 e os proficientes para a reparação de erros no DNA (MMR-proficient), bem como com aqueles que tinham expressão de SOX2. No entanto, não foi encontrado valor prognóstico ou preditivo para a expressão de HMGA1. Por forma a detetar CSCs do colon usando o sistema SORE6, transduzimos duas linhagens celulares de cancro colorretal, HCT116 e SW480, com o vetor SORE6 e, de seguida, estabelecemos duas subpopulações celulares, SORE6⁺ (GFP⁺) e SORE6ˉ (GFPˉ), através de ‘’Fluorescence Activated Cell Sorting’’ (FACS). Embora a expressão de SOX2 tenha sido mais elevada nas células SORE6⁺ (CSC-like), as HCT116 SORE6⁺ apresentaram menor expressão de HMGA1 em comparação com as células SORE6ˉ. Apenas a linha celular SW480 teve maior expressão destas duas proteínas nas células SORE6+. De seguida, realizámos a sobre-expressão de HMGA1, transduzindo ambas as subpopulações SORE6ˉ e SORE6⁺ das linhas HCT116 e SW480, com um vetor lentivírico codificante para a HMGA1 e induzível por doxiciclina (DOX), para compreender se esta proteína tem algum papel na aquisição de características de estaminalidade nas células de cancro do cólon e avaliar as mudanças fenotípicas relacionadas com o estabelecimento de CSCs no cólon. Infelizmente, não tivemos sucesso na infeção das SW480. As células HCT116 transduzidas com HMGA1 apresentaram um aumento na expressão de GFP apenas nas células SORE6⁺ transduzidas com HMGA1, conforme observado por citometria de fluxo. Quanto à expressão de SOX2 e C-MYC nestas células, o SOX2 pareceu ser inibido pela HMGA1, enquanto C-MYC pareceu aumentar por ação desta proteína. O OCT4 apresentou níveis extremamente baixos de expressão em ambas as linhas celulares. Nos ensaios funcionais, não foram observadas diferenças significativas na estaminalidade nas células SORE6 transduzidas com HMGA1 após a realização de ensaios clonogénicos e de resistência ao 5-FU.2025-12-22T00:00:00Z2023-12-19T00:00:00Z2023-12-19info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisapplication/pdfhttp://hdl.handle.net/10773/40519engMonteiro, Inês Filipa Soaresinfo:eu-repo/semantics/embargoedAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-02-22T12:19:15Zoai:ria.ua.pt:10773/40519Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T03:10:27.783656Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Evaluation of the role of HMGA1 protein in colon cancer stem cells
title Evaluation of the role of HMGA1 protein in colon cancer stem cells
spellingShingle Evaluation of the role of HMGA1 protein in colon cancer stem cells
Monteiro, Inês Filipa Soares
Colorectal cancer
Cancer stem cells
HMGA1
SORE6
Viral transduction
Stemness
title_short Evaluation of the role of HMGA1 protein in colon cancer stem cells
title_full Evaluation of the role of HMGA1 protein in colon cancer stem cells
title_fullStr Evaluation of the role of HMGA1 protein in colon cancer stem cells
title_full_unstemmed Evaluation of the role of HMGA1 protein in colon cancer stem cells
title_sort Evaluation of the role of HMGA1 protein in colon cancer stem cells
author Monteiro, Inês Filipa Soares
author_facet Monteiro, Inês Filipa Soares
author_role author
dc.contributor.author.fl_str_mv Monteiro, Inês Filipa Soares
dc.subject.por.fl_str_mv Colorectal cancer
Cancer stem cells
HMGA1
SORE6
Viral transduction
Stemness
topic Colorectal cancer
Cancer stem cells
HMGA1
SORE6
Viral transduction
Stemness
description Colorectal cancer, with over 1.9 million cases in 2020 and ranking second in cancer-related deaths, is increasing in highly developed countries. Cancer stem cells (CSCs), related to tumour initiation and chemotherapy resistance, are a significant focus in cancer research. Transcription factors (TFs) like SOX2, CMYC, and OCT4 are used to identify these cells. The lentiviral SORE6 reporter system, developed by Tang et al. (2015), allows the detection and characterization of CSCs by using a green fluorescent protein (GFP) under the control of a promoter with binding sites for SOX2 and OCT4. HMGA1 protein, overexpressed in several types of cancer, influences gene expression through chromatin changes, and is linked to stemness TFs, such as SOX2, OCT4, KLF4, and NANOG. In colorectal cancer, HMGA1 is crucial for maintaining a stem cell phenotype. The aim of this study was to investigate and establish the functional relevance of this protein in colon CSCs. We started by evaluating if HMGA1 levels, assessed by immunohistochemistry in 219 stage II CRC patient samples, were statistically correlated with clinicopathological and molecular characteristics of the tumours. We found that tumours with high HMGA1 expression were significantly associated with MMR-proficiency and SOX2 expression. Nevertheless, no prognostic or predictive value for HMGA1 expression was found. Aiming to use the SORE6 reporter to detect CSCs, a transduction of two CRC cell lines, HCT116 and SW480, with the SORE6 reporter vector was performed, and later two cell subpopulations, SORE6⁺ (GFP⁺) and SORE6ˉ (GFPˉ) were established through Fluorescence Activated Cell Sorting (FACS). Even though SOX2 expression was higher in SORE6⁺ cells (CSC-like), as expected, HCT116 cells showed less HMGA1 expression, when comparing to SORE6ˉ cells. Only SW480 had more expression of these two proteins in SORE6⁺ cells. Then, HMGA1 overexpression was performed by transducing both SORE6ˉ and SORE6⁺ sub-populations of HCT116 and SW480 cell lines with a DOX-inducible lentiviral vector, to understand if this protein has a role in the acquisition of stemness characteristics by colon cells and to evaluate phenotypic changes related to the establishment of colon CSCs. Unfortunately, the infection of SW480 revealed unsuccessful. The HCT116 HMGA1 transduced cells had a GFP gain was observed, through flow cytometry, but only in SORE6⁺ HMGA1 transduced cells. Regarding SOX2 and C-MYC expression in these cells, while SOX2 appeared to be inhibited by HMGA1, C-MYC seemed up-regulated by this protein. OCT4 had very low levels of expression in both cells and was not further evaluated. Through functional assays, no significant differences in stemness were observed after transducing SORE6 cells with HMGA1, either by using clonogenic or 5-FU resistance assays.
publishDate 2023
dc.date.none.fl_str_mv 2023-12-19T00:00:00Z
2023-12-19
2025-12-22T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
format masterThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10773/40519
url http://hdl.handle.net/10773/40519
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/embargoedAccess
eu_rights_str_mv embargoedAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799137755495661568